Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T55729 | Target Info | |||
Target Name | Stress-activated protein kinase 2b (p38 beta) | ||||
Synonyms | Stress-activated protein kinase-2; SAPK2b; SAPK2; PRKM11; P38b; P38-2; P38 Mitogen-activated protein kinase beta; Mitogen-activated protein kinase p38 beta; Mitogen-activated protein kinase 11; MAPK 11; MAP kinase p38 beta; MAP kinase 11 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | MAPK11 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: Nilotinib | Ligand Info | |||||
Structure Description | Crystal Structure of Human Mitogen Activated Protein Kinase 11 (p38 beta) in complex with Nilotinib | PDB:3GP0 | ||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | No | [1] |
PDB Sequence |
MRAGFYRQEL
13 NKTVWEVPQR23 LQGLRPVGSV38 CSAYDARLRQ48 KVAVKKLSRP58 FQSLIHARRT 68 YRELRLLKHL78 KHENVIGLLD88 VFTPATSIED98 FSEVYLVTTL108 MGADLNNIVK 118 CQALSDEHVQ128 FLVYQLLRGL138 KYIHSAGIIH148 RDLKPSNVAV158 NEDCELRILD 168 FGEEMGYVAT185 RWYRAPEIML195 NWMHYNQTVD205 IWSVGCIMAE215 LLQGKALFPG 225 SDYIDQLKRI235 MEVVGTPSPE245 VLAKISSEHA255 RTYIQSLPPM265 PQKDLSSIFR 275 GANPLAIDLL285 GRMLVLDSDQ295 RVSAAEALAH305 AYFSQYHDPE315 DEPEAEPYDE 325 SVEAKERTLE335 EWKELTYQEV345 LSF
|
|||||
|
VAL30
4.497
VAL38
3.876
ALA51
3.681
VAL52
3.913
LYS53
3.520
ARG67
3.452
ARG70
4.061
GLU71
2.778
LEU74
3.827
LEU75
3.792
LEU78
4.005
VAL83
3.525
ILE84
3.423
LEU104
3.711
VAL105
4.753
|
|||||
Ligand Name: 5-(2-Chloro-4-Fluorophenyl)-1-(2,6-Dichlorophenyl)-7-[1-(1-Methylethyl)piperidin-4-Yl]-3,4-Dihydroquinazolin-2(1h)-One | Ligand Info | |||||
Structure Description | The structure of p38beta C119S, C162S in complex with a dihydroquinazolinone inhibitor | PDB:3GC9 | ||||
Method | X-ray diffraction | Resolution | 2.05 Å | Mutation | Yes | [2] |
PDB Sequence |
GPRAGFYRQE
12 LNKTVWEVPQ22 RLQGLRPVGS32 GAYGSVCSAY42 DARLRQKVAV52 KKLSRPFQSL 62 IHARRTYREL72 RLLKHLKHEN82 VIGLLDVFTP92 ATSIEDFSEV102 YLVTTLMGAD 112 LNNIVKSQAL122 SDEHVQFLVY132 QLLRGLKYIH142 SAGIIHRDLK152 PSNVAVNEDS 162 ELRILDFGLA172 ATRWYRAPEI193 MLNWMHYNQT203 VDIWSVGCIM213 AELLQGKALF 223 PGSDYIDQLK233 RIMEVVGTPS243 PEVLAKISSE253 HARTYIQSLP263 PMPQKDLSSI 273 FRGANPLAID283 LLGRMLVLDS293 DQRVSAAEAL303 AHAYFSQYHD313 PEDEPEAEPY 323 DESVEAKERT333 LEEWKELTYQ343 EVLSF
|
|||||
|
VAL30
3.570
ALA34
3.714
TYR35
3.625
VAL38
3.531
CYS39
4.533
ALA51
3.212
VAL52
3.741
LYS53
3.551
LEU75
3.939
ILE84
4.117
LEU86
3.974
LEU104
3.595
THR106
3.230
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Crystal Structure of Human Mitogen Activated Protein Kinase 11 (p38 beta) in complex with Nilotinib | ||||
REF 2 | The three-dimensional structure of MAP kinase p38beta: different features of the ATP-binding site in p38beta compared with p38alpha. Acta Crystallogr D Biol Crystallogr. 2009 Aug;65(Pt 8):777-85. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.